# Lorazepam for the Treatment of Status Epilepticus in Children

> **NCT00114569** · PHASE1 · COMPLETED · sponsor: **Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)** · enrollment: 69 (actual)

## Conditions studied

- Status Epilepticus

## Interventions

- **DRUG:** lorazepam

## Key facts

- **NCT ID:** NCT00114569
- **Lead sponsor:** Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** 2007-04
- **Final completion:** 2009-02
- **Target enrollment:** 69 (ACTUAL)
- **Last updated:** 2016-05-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00114569

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00114569, "Lorazepam for the Treatment of Status Epilepticus in Children". Retrieved via MORVS 2026-10-22 from https://api.morvs.ai/clinical/NCT00114569. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*